12种肿瘤标志物联合检测的临床应用及评价
Journal of Chongqing Medical University(2006)
Abstract
近年来,恶性肿瘤已成为人类第二大死亡病因.CT等物理诊断往往只能发现中晚期病例,单一指标肿瘤标志物敏感性不高,而上海数康生物科技有限公司研发并生产的多肿瘤标志物蛋白芯片诊断系统(简称C-12),通过12种肿瘤标志物的联合检测,阳性率明显提高,在临床上有很好的辅助诊断价值.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined